Deerfield Management Company, L.P. (Series C) Insulet Corp Transaction History
Deerfield Management Company, L.P. (Series C)
- $5.38 Billion
- Q3 2024
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Insulet Corp stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 109,600 shares of PODD stock, worth $29.2 Million. This represents 0.47% of its overall portfolio holdings.
Number of Shares
109,600
Previous 112,433
2.52%
Holding current value
$29.2 Million
Previous $22.7 Million
12.43%
% of portfolio
0.47%
Previous 0.48%
Shares
9 transactions
Others Institutions Holding PODD
# of Institutions
687Shares Held
62.6MCall Options Held
640KPut Options Held
881K-
Vanguard Group Inc Valley Forge, PA8.47MShares$2.26 Billion0.04% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.77MShares$2.07 Billion0.39% of portfolio
-
Black Rock Inc. New York, NY6.06MShares$1.62 Billion0.03% of portfolio
-
State Street Corp Boston, MA2.91MShares$777 Million0.03% of portfolio
-
Baillie Gifford & CO2.28MShares$607 Million0.4% of portfolio
About INSULET CORP
- Ticker PODD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 69,403,600
- Market Cap $18.5B
- Description
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...